NAGLAZYME (Page 5 of 5)

Packaging Components

NDC 68135-020-01


5 mg/5 mL (1 mg/mL)

Concentrated Solution For Intravenous Infusion Only

Must be diluted prior to use.

Rx Only

Naglazyme Carton
(click image for full-size original)

Naglazyme Carton

NAGLAZYME galsulfase solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68135-020
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
# Item Code Package Description Multilevel Packaging
1 NDC:68135-020-01 1 VIAL in 1 CARTON contains a VIAL
1 5 mL in 1 VIAL This package is contained within the CARTON (68135-020-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125117 06/09/2005
Labeler — BioMarin Pharmaceutical Inc. (079722386)

Revised: 04/2020 BioMarin Pharmaceutical Inc.

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.